eScholarship
metadata only
Validation of the GeneXpert® CT/NG Assay for use with Male Pharyngeal and Rectal Swabs.
OBJECTIVES: The GeneXpert® CT/NG (Cepheid, Sunnyvale, CA) assay is a point-of-care (POC) molecular diagnostic assay designed to rapidly test for the presence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC). However, the test is only approved for vaginal swabs, urine, and endocervical sw
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study#966245
- CASUS: Validation for Detection of Precursor Lesions#1095306
- Plasmid DNA mediated vancomycin-resistant Staphylococcus aureus (VRSA) from cases of urinary tract infection.#265870
- Detecting and typing Chlamydia trachomatis strains in metagenomes using the MetaChlam pipeline#1006947
- Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice#800752
Record · ID 1133056
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive